Literature DB >> 30517669

Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study.

Elena Vegni1, Daniela Gilardi2, Stefanos Bonovas2,3, Bianca E Corrò2, Julia Menichetti1, Daniela Leone1, Allocca Mariangela2,3, Federica Furfaro2, Silvio Danese2,3, Gionata Fiorino2,3.   

Abstract

BACKGROUND: Inflammatory bowel diseases [IBD] are characterised by significant quality of life [QoL] impairment, as well as illness perception. Assessing illness perception may help in optimising the management of IBD patients.
METHODS: In this single-centre, observational, transversal study, consecutive adult IBD patients were enrolled and stratified according to disease activity [active/remission]. The Revised Illness Perception Questionnaire [IPQ-R], based on identity, opinions, and causes of their disease was administered to all patients. Comparison within IPQ-R parameters was done between clinically active patients and those in remission.
RESULTS: A total of 201 patients were enrolled (Crohn's disease [CD] = 47%). The most frequently reported IBD-related symptoms were fatigue [86.9%], loss of strength [83.3%], pain [80%], and weight loss [68.2%]. Active patients reported significantly more frequently fatigue [p = 0.005], sore eyes [p = 0.046], and sleep difficulties [p = 0.001], and reported more symptoms than controls [p = 0.023]. Overall, the patients considered stress [84.1%], altered immunity [69.32%], family problems [49.4%], and emotional status [40.9%] as the main causes of IBD. Work overload was more frequently considered as a disease cause in active patients than in those in remission [p = 0.002]. Smoking, family history, and previous inadequate therapies were considered as a relevant risk factor for illness by only 20% of patients. Active IBD patients had more negative thoughts on prognosis [p = 0.001] and more negative emotions [p < 0.0001]. Patients in remission were significantly more convinced about treatment control [p = 0.007] and had clearer understanding of illness [p = 0.009].
CONCLUSIONS: Illness perception is impaired in IBD patients. Adequate educational and psychological support may be helpful in the optimal management of IBD patients.
Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; Perception; inflammatory bowel disease; psychology; ulcerative colitis

Mesh:

Year:  2019        PMID: 30517669     DOI: 10.1093/ecco-jcc/jjy183

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

1.  Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease.

Authors:  Kendra J Kamp; Kindra Clark-Snustad; Mitra Barahimi; Scott Lee
Journal:  Gastroenterol Nurs       Date:  2022 Jan-Feb 01       Impact factor: 0.978

2.  Illness perception in patients with eating disorders: clinical, personality, and food addiction correlates.

Authors:  Zaida Agüera; Nadine Riesco; Eduardo Valenciano-Mendoza; Roser Granero; Isabel Sánchez; Alba Andreu; Susana Jiménez-Murcia; Fernando Fernández-Aranda
Journal:  Eat Weight Disord       Date:  2021-01-02       Impact factor: 4.652

3.  Polish Adaptation and Validation of the Revised Illness Perception Questionnaire (IPQ-R) in Cancer Patients.

Authors:  Aneta Pasternak; Magdalena Poraj-Weder; Katarzyna Schier
Journal:  Front Psychol       Date:  2021-05-13

4.  The new frontier: Certifying quality standards in the inflammatory bowel disease care.

Authors:  Gionata Fiorino; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2021-07-10       Impact factor: 6.866

5.  Illness perception, mood state and disease-related knowledge level of COVID-19 family clusters, Hunan, China.

Authors:  Haiyang Liu; Xuting Li; Qiongni Chen; Yamin Li; Chaoying Xie; Man Ye; Jin Huang
Journal:  Brain Behav Immun       Date:  2020-05-18       Impact factor: 7.217

6.  Distinct clinical phenotypes for Crohn's disease derived from patient surveys.

Authors:  Tianyun Liu; Lichy Han; Mera Tilley; Lovisa Afzelius; Mateusz Maciejewski; Scott Jelinsky; Chao Tian; Matthew McIntyre; Nan Bing; Kenneth Hung; Russ B Altman
Journal:  BMC Gastroenterol       Date:  2021-04-09       Impact factor: 3.067

7.  The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study.

Authors:  Tiziana Larussa; Danilo Flauti; Ludovico Abenavoli; Luigi Boccuto; Evelina Suraci; Raffaella Marasco; Maria Imeneo; Francesco Luzza
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

8.  Effectiveness of a Telephone-Based Motivational Intervention for Smoking Cessation in Patients With Crohn Disease: A Randomized, Open-Label, Controlled Clinical Trial.

Authors:  Ester Navarro Correal; Francesc Casellas Jorda; Natalia Borruel Sainz; Virginia Robles Alonso; Claudia Herrera de Guise; Arantxa Ibarz Casas; Josep Maria Sánchez García; Genoveva Vila Morte; Carmen Fuentelsaz Gallego
Journal:  Gastroenterol Nurs       Date:  2021 Nov-Dec 01       Impact factor: 0.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.